Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/c0/5e/76/c05e760e-55a0-b5b3-9722-8dbcf60a004c/mza_6586002612235378273.png/600x600bb.jpg
HealthTree Podcast for Multiple Myeloma
HealthTree Podcast for MM
178 episodes
2 weeks ago
HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.
Show more...
Health & Fitness
RSS
All content for HealthTree Podcast for Multiple Myeloma is the property of HealthTree Podcast for MM and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.
Show more...
Health & Fitness
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/40464506/98fa7fe0b2bdfb1b.png
The 2024 Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson
HealthTree Podcast for Multiple Myeloma
1 hour 15 minutes 32 seconds
1 year ago
The 2024 Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson
The year 2024 brings new promise in multiple myeloma with a wide variety of treatment options avaiable for both newly diagnosed and relapsed/refractory patients. Learn about the progress being made and the very latest in determining risk at diagnosis, strategies for smoldering myeloma patients, optimal treatments for newly diagnosed patients, things to consider at first relapse and beyond. Dr. Robert Orlowski will review advances in CAR T therapies, bispecific antibodies, targeted therapies and combination approaches and clinical trials to watch as the research continues advancing at a rapid pace in myeloma.  Thanks to our episode sponsor, GSK.
HealthTree Podcast for Multiple Myeloma
HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.